Dr. Yuki Morimoto attended undergrad at Chiba University in Japan where he majored in Medicine, and then obtained a medical license. After working as a Otolaryngology-head and neck surgeon, Dr. Morimoto went on to complete his graduate education at Graduate School of Medicine at Chiba University as a member of Leading Graduate School Program sponsored by JSPS. There he worked with Yoshitaka Okamoto and Toshinori Nakayama, where his main interest was exploring novel mechanisms which pathogenic memory Th2 cells exacerbated airway fibrosis associated with chronic allergic inflammations. After obtaining his Ph.D., Dr. Morimoto investigated memory type Th cell functions as an assistant professor of Future Medicine Education and Research Center at Chiba University.

Research Statement

Dr. Morimoto’s major research goal is understanding the molecular mechanisms which define various Th populations beyond their master regulators. He believes that we may not yet understand the detailed classification of Th populations. He is interested in more detailed understanding which types of mechanisms regulate to differentiate, act and linger on for various Th cells. His current focus is observing global gene expressions and large numbers of protein productions at the single-cell level in regards to characterizing various types of Th cells.


Graduate School of Medicine, Chiba University
Ph.D., 2017

School of Medicine, Chiba University
M.D., 2009


Postdoctoral Fellow, NIAMS, NIH
November 2018 - present

Assistant Professor, Future Medicine Education and Research Center, School of Medicine, Chiba University
April 2017 - October 2018

Last Updated: December 2018